The Toronto-Dominion Bank Acquires 5.4% Stake in UroGen Pharma Ltd.

The Toronto-Dominion Bank (TD Bank) and its subsidiary, TD Securities Inc. (TDSI), have filed a joint Schedule 13G disclosing a combined beneficial ownership of 2,618,020 ordinary shares of UroGen Pharma Ltd. (URGN). This position represents approximately 5.4% of the company's outstanding shares. Specifically, TD Bank reports sole voting and dispositive power over 2,616,714 shares, while TDSI holds sole power over 1,306 shares. As the parent company, TD Bank may be deemed to hold an indirect interest in the shares held by TDSI. The filing, dated May 15, 2026, indicates that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. This filing marks a significant increase from a zero-position reported in previous periods, establishing a new major stake in the Israel-based pharmaceutical company.